Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Office Of Generic Drugs Director Has Brand Industry Background

This article was originally published in The Pink Sheet Daily

Executive Summary

Gregory Geba mostly has brand experience, but will be expected to lead OGD’s reorganization as it implements a new user fee program.


Related Content

FDA Mines Small Field Of Industry Candidates To Fill Executive Vacancies
FDA Searches Small Industry Candidate Pool To Fill Executive Vacancies
Pharmaceutical Quality And Generic Drugs: Janet Woodcock Explains Her Vision
FDA Generics Director’s Departure Shows Why Chemistry Matters
FDA’s Generics Office Loses Another Director As Geba Makes Quick Exit
CDER Taps Genzyme Exec As Deputy Director For Science Operations
Incoming FDA Medical Products Official Has Strong Industry Ties
Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties
Generic Facility Fee Unlikely To Be Charged Until A Few Months After GDUFA Implementation
FDA's Buehler To Join Teva


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts